Plasma drug concentrations and physiological measures in 'dance party' participants

被引:41
作者
Irvine, RJ
Keane, M
Felgate, P
McCann, U
Callaghan, PD
White, JM
机构
[1] Univ Adelaide, Med Sch N, Dept Clin & Expt Pharmacol, Adelaide, SA 5005, Australia
[2] Forens Sci Ctr, Adelaide, SA, Australia
[3] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[4] Drug & Alcohol Serv Council, Adelaide, SA, Australia
关键词
MDMA; ecstasy; pharmacokinetics; neurotoxicity; amphetamines; drug abuse;
D O I
10.1038/sj.npp.1300896
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The increasing use of (+/-) 3,4-methylenedioxymethamphetamine ( MDMA) in the setting of large dance parties ('raves') and clubs has been the source of some concern, because of potential acute adverse events, and because animal studies suggest that MDMA has the potential to damage brain serotonin (5-HT) neurons. However, it is not yet known whether MDMA, as used in the setting of dance parties, leads to plasma levels of MDMA that are associated with toxicity to 5-HT neurons in animals. The present study sought to address this question. Plasma MDMA concentrations, vital signs, and a variety of blood and urine measures were obtained prior to, and hours after, individuals attended a dance party. After the dance party, subjects were without clinical complaints, had measurable amounts of residual MDMA in plasma, and nearly half of the subjects also tested positive for methamphetamine, another amphetamine analog that has been shown to have 5-HT neurotoxic potential in animals. Plasma concentrations of MDMA did not correlate with self-reported use of 'ecstasy' and, in some subjects, overlapped with those that have been associated with 5-HT neurotoxicity in non-human primates. Additional subjects were likely to have had similar concentrations while at the dance party, when one considers the reported time of drug ingestion and the plasma half-life of MDMA in humans. Hematological and biochemical analyses were generally unremarkable. Moderate increases in blood pressure, heart rate and body temperature were observed in the subjects with the highest MDMA plasma concentrations. These findings are consistent with epidemiological findings that most people who use MDMA at dance parties do not develop serious clinical complications, and suggest that some of these individuals may be at risk for developing MDMA-induced toxicity to brain serotonin neurons.
引用
收藏
页码:424 / 430
页数:7
相关论文
共 31 条
[1]   Hyponatremia among runners in the Boston Marathon [J].
Almond, CSD ;
Shin, AY ;
Fortescue, EB ;
Mannix, RC ;
Wypij, D ;
Binstadt, BA ;
Duncan, CN ;
Olson, DP ;
Salerno, AE ;
Newburger, JW ;
Greenes, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1550-1556
[2]  
BASELT RC, 2002, DISPOSITION TOXIC DR, P687
[3]   Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations [J].
Bowyer, JF ;
Young, JF ;
Slikker, W ;
Itzak, Y ;
Mayorga, AJ ;
Newport, GD ;
Ali, SF ;
Frederick, DL ;
Paule, MG .
NEUROTOXICOLOGY, 2003, 24 (03) :379-390
[4]   THE HYPERTHERMIC AND NEUROTOXIC EFFECTS OF ECSTASY (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) IN THE DARK-AGOUTI (DA) RAT, A MODEL OF THE CYP2D6 POOR METABOLIZER PHENOTYPE [J].
COLADO, MI ;
WILLIAMS, JL ;
GREEN, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) :1281-1289
[5]   The content of ecstasy tablets: implications for the study of their long-term effects [J].
Cole, JC ;
Bailey, M ;
Sumnall, HR ;
Wagstaff, GF ;
King, LA .
ADDICTION, 2002, 97 (12) :1531-1536
[6]   Effects of repeated oral methamphetamine administration in humans [J].
Comer, SD ;
Hart, CL ;
Ward, AS ;
Haney, M ;
Foltin, RW ;
Fischman, MW .
PSYCHOPHARMACOLOGY, 2001, 155 (04) :397-404
[7]   Human pharmacology of MDMA -: Pharmacokinetics, metabolism, and disposition [J].
de la Torre, R ;
Farré, M ;
Roset, PN ;
Pizarro, N ;
Abanades, S ;
Segura, M ;
Segura, J ;
Camí, J .
THERAPEUTIC DRUG MONITORING, 2004, 26 (02) :137-144
[8]   Non-linear pharmacokinetics of MDMA ('ecstasy') in humans [J].
de la Torre, R ;
Farré, M ;
Ortuño, J ;
Mas, M ;
Brenneisen, R ;
Roset, PN ;
Segura, J ;
Camí, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (02) :104-109
[9]   The health effects of ecstasy: a literature review [J].
Gowing, LR ;
Henry-Edwards, SM ;
Irvine, RJ ;
Ali, RL .
DRUG AND ALCOHOL REVIEW, 2002, 21 (01) :53-63
[10]   The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") [J].
Green, AR ;
Mechan, AO ;
Elliott, JM ;
O'Shea, E ;
Colado, MI .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :463-508